Maybe Logo Early Access

Tools / Inside Trading Tracker

Inside Trading Tracker

Track insider trading activity at publicly traded companies to understand how executives are trading their shares.

    Ainos, Inc. (AIMDW) Insider Trading Activity

    Healthcare • Medical Devices • 46 employees

    Ainos, Inc., a healthcare company, engages in developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications. The company offers COVID-19 antigen rapid test kit and Ainos' cloud-based test management App, a cloud-based test management platform comprising an antigen rapid test kit, a personal application, and an enterprise app; COVID-19 nucleic acid test; volatile organic compounds point-of-care testing; Very Low-Dose Oral Interferon Alpha, a low-dose oral interferon alpha formulation based IFN-a's broad treatment applications; and Synthetic RNA developing a SRNA technology platform in Taiwan. It also provides women's health, pneumonia, Ainos Pen, AI Nose, and other products. Ainos, Inc. was formerly known as Amarillo Biosciences, Inc. and changed its name to Ainos, Inc. in May 2021. The company was incorporated in 1984 and is based in San Diego, California.

    Total Value

    $350,190.19

    Total Shares

    751,634

    Average Trade Value

    $23,346.01

    Most Active Insider

    Tsai Chun Hsien

    Total Activity: $115,956

    Largest Single Transaction

    $103,515

    by Tsai Chun Hsien on Nov 26, 2024

    30-Day Activity

    0 Transactions

    Volume: 0 shares
    Value: $0

    Name
    Position
    Date
    Shares
    Value
    Holdings
    Type
    Director
    Nov 26, 2024 208,797 $96,047 323,900 (+64.5%) Grant
    Ceo, President, Chairman
    Director, Officer
    Nov 26, 2024 225,032 $103,515 547,862 (+41.1%) Grant
    CFO
    Officer
    Nov 26, 2024 19,019 $8,749 22,376 (+85.0%) Grant
    Director
    Nov 26, 2024 204,721 $94,172 327,432 (+62.5%) Grant
    CFO
    Officer
    Nov 22, 2024 4,000 $1,840 7,357 (+54.4%) Grant
    Ceo, President, Chairman
    Director, Officer
    Nov 22, 2024 4,000 $1,840 326,830 (+1.2%) Grant
    Director
    Nov 22, 2024 4,000 $1,840 119,103 (+3.4%) Grant
    Director
    Nov 22, 2024 4,000 $1,840 126,711 (+3.2%) Grant
    Director
    Nov 15, 2024 4,200 $1,848 122,711 (+3.4%) Grant
    Ceo, President, Chairman
    Director, Officer
    Nov 15, 2024 3,000 $1,320 322,830 (+0.9%) Grant
    Director
    Nov 15, 2024 4,200 $1,848 115,103 (+3.6%) Grant
    Ceo, President, Chairman
    Director, Officer
    Sep 15, 2024 17,511 $9,281 319,830 (+5.5%) Grant
    CFO
    Officer
    Sep 15, 2024 3,357 $1,779 3,357 (+100.0%) Grant
    Director
    Sep 15, 2024 23,280 $12,338 118,511 (+19.6%) Grant
    Director
    Sep 15, 2024 22,517 $11,934 110,903 (+20.3%) Grant